Your Health Plan:
Your Health Plan:
Not SelectedWELIREG (belzutifan) is a brand-name prescription drug for treatment of Von Hippel-Lindau Syndrome and Central Nervous System Cysts. WELIREG is a hypoxia-inducible factor inhibitor. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $33300-39000.
Patient Assistance Prorgams are found:
No other option is found for WELIREG